France’s drug safety agency warned on Monday of potentially serious side effects of treatments being tested against the new coronavirus after the deaths of three people possibly linked to self-medication.
Another two dozen patients have reported undesirable side effects after taking Plaquenil – the brand name of hydroxychloroquine – as well as other medicines such as the antiretroviral Kaletra, the agency’s head Dominique Martin told AFP.
…
The drug safety agency (ANSM) began boosting its surveillance two weeks ago of trials of drugs against COVID-19, “in particular when they are used outside of clinical trials of chloroquine, hydroxychloroquine, azithromycin, lopinavir/ritonavir (Kaletra), tocilizumab (and) colchicine,” Martin said.
Full story at France24
Article submitted by Bogdan Sunder